Weill Cornell Medicine has entered into an agreement with Top Spring Huaxia Medical Investment to help it develop a modern outpatient diagnostic clinic in Shenzhen, China.
Cornell biomedical engineers have developed specialized white blood cells – dubbed "super natural killer cells" – that seek out cancer cells in lymph nodes with only one purpose: destroy them.
At the Cornell Entrepreneurship Summit in New York City Nov. 6, CEOs presented, students pitched business ideas, and President Garrett and spoke of Cornell's entrepreneurial roots.
Six Cornell researchers will receive grants totaling more than
$3 million as part of the National Science Foundation Secure and Trustworthy Cyberspace program.
Obesity impairs the body’s ability to use vitamin A appropriately and leads to deficiencies of the vitamin in major organs, according to new research conducted at Weill Cornell Medicine.
Weill Cornell Medicine finds a combination therapy lacking many debilitating effects manages mantle cell lymphoma, shrinking the malignancy and inducing remissions in most patients.
The Runway Startup Postdoc Program – described as "part business school, part research institution, part startup incubator" – is designed to advance the participants' research and launch new business ventures.
High levels of vitamin C kill certain kinds of colorectal cancers in cell cultures and mice, according to a new study from Weill Cornell Medicine investigators.
Weill Cornell Medicine researchers have found a new therapeutic approach to an aggressive form of lymphoma that may greatly increase the efficacy of treatment and result in better patient outcomes.
